Overview
Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
Status:
Completed
Completed
Trial end date:
2009-05-31
2009-05-31
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
To collect the outcome of frozen-thawed embryo transfer cycles after the embryos are cryopreserved up to at least 1 year in Trial P05787 (NCT00696800), in order to estimate the cumulative pregnancy rate for each treatment group.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Follicle Stimulating Hormone
Ganirelix
Progesterone
Criteria
Inclusion Criteria:- Participants from whom embryos have been cryopreserved in Base Trial P05787
(NCT00696800), of which at least one embryo is thawed for use in a subsequent FTET
cycle;
- Able and willing to give informed consent.
Exclusion Criteria:
- None